Vaccination is became a heavy move against Corona Virus (Covid-19) . It is studied that a person is 99% safe who have taken all 2 of the doses of the vaccine . India has the capability of producing 8.2 billion doses of vaccination in a day. India had supplied around 52.7 crore doses of vaccine in more than 70 countries. Canada gave an order of vaccination around 5 times its Population. But this became a but bad for the country cause in many cities deficiency of vaccines accured. 109 million people got the first dose and around 17 million people got complete vaccination and Government had targeted to give first dose of vaccination to around 250 million people till July and complete vaccination to 100 million people till the same date . Andhra Pradesh had received 370,000 doses of Covishield and 20,000 of Covaxin. It was decided that only Covishield would be administered. The state aims to vaccinate 32,000 people a day. However, on the first two days, only 61 and 47.8 per cent of those days' targets could be vaccinated. There were two cases of adverse events, but neither required hospitalization.4,319 health workers were administered the vaccine on the first day, and there were 51 minor and one major cases of adverse effects.By day three, four people had been admitted to hospitals following complications, of which three had been later discharged.Maharashtra received 963,000 doses of Covishield and 20,000 doses of Covaxin. 785,000 health workers had registered to get the vaccination. 14,883 health workers in Maharashtra given COVID-19 vaccine on Tuesday In Mumbai, only 1,926 people could be vaccinated on the first day, due to a combination of low turnout and technical problems with the software. The vaccination drive was temporarily suspended due to the technical glitches in the software alerting people to their vaccination appointments.The national vaccination drive began on 16 January 2021, across 3,006 vaccination centres.
Each vaccination centre will offer either Covishield or Covaxin, but not both. Some states have decided to use only Covishield as the “default option” and keep their Covaxin doses as a “buffer stock”. Since Covaxin has not completed phase-3 trials, those receiving it will need to sign a signed consent form.
On the first day (16 January), 1,65,714 people received the vaccination. Difficulties in uploading beneficiary lists at some sites caused delays. In the first three days, 6,31,417 people were vaccinated. Of these, 0.18% reported side-effects and nine people (0.002%) were admitted to hospitals for observation and treatment. Within those first days, there was concern about low turnout, due to a combination of vaccine safety concerns, technical problems with the software used, and misinformation.
By March 1, only 14 million healthcare and frontline workers had been vaccinated, falling short of the original goal of 30 million.
